Notably, at 72–96 h post-treatment, caspase-3 cleavage was induced in mTZ3-LNP-treated EBV-positive cancer cells, including C666-1 cells that experienced only abortive lytic cycle reactivation. The gene discussed is CASP3; the disease is cancer.